Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Esketamine as Treatment for Chronic Pain Due to Endometriosis: a RCT Study — Stella

Home/Endometriosis/Esketamine as Treatment for Chronic Pain Due to Endometriosis: a RCT Study

View on ClinicalTrials.gov

Recruiting

Back to Endometriosis trials

Esketamine as Treatment for Chronic Pain Due to Endometriosis: a RCT Study

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

Netherlands

Nederlandse Endometriose Kliniek, Reinier de Graaf Gasthuis, Delft

Key details

Phase

Large-scale testing

Sponsor

Reinier de Graaf Groep

Enrollment target

~56 participants

Started

March 2024

Primary completion

January 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 50 Years

Sex

Female only

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.